IDEXX Laboratories Trading Volume Surges 40.6% to $367 Million, Ranked 234th Despite Stock Price Decline

On March 25, 2025, IDEXX Laboratories (IDXX) saw a trading volume of $367 million, marking a 40.6% increase from the previous day. This surge placed IDEXX in the 234th position in terms of trading volume for the day. However, despite the high trading volume, the stock price of IDEXX Laboratories declined by 1.40%.

Over the past year, several insiders of IDEXX Laboratories have sold significant stakes in the company, which has drawn the attention of shareholders. While insider selling can have various explanations, it is generally more informative to observe insider buying. However, if multiple insiders are selling shares over a specific period, it may warrant further investigation.

In the last twelve months, the most substantial sale by an insider occurred when Independent Director M. Szostak sold shares worth $1.4 million at a price of $466 per share. Although insider selling is typically seen as a negative indicator, this particular sale was made at a price well above the current stock price of $421, making it difficult to draw strong conclusions from this transaction alone.

Notably, there were no insider purchases of IDEXX Laboratories shares in the last year. This lack of buying activity, combined with the significant selling by insiders, suggests that insiders may not view the current stock price as undervalued. Additionally, insiders of IDEXX Laboratories own approximately $333 million worth of shares, which represents about 1.0% of the company. While this level of insider ownership is relatively low, it does indicate that insiders have a financial stake in the company's long-term success.